Deals channel feed

Mer­ck, Evax­ion ex­pand col­lab­o­ra­tion with in­fec­tious dis­ease vac­cine pact

7 months ago
AI

Bio­gen walks away from Sage's es­sen­tial tremor drug af­ter mid-stage flop, pil­l's fu­ture in ques­tion

7 months ago
R&D

Flag­ship’s AI biotech Gen­er­ate lands $65M up­front in No­var­tis deal, as first clin­i­cal read­outs near

7 months ago
AI

Is Sanofi mak­ing a move in­to obe­si­ty? French phar­ma in­vests $27M in­to Ven­tyx

7 months ago
Pharma

Telix buys ra­dio­phar­ma­cy net­work for $230M up front to ex­pand US ca­pac­i­ty 

7 months ago
Manufacturing

A VC-backed ge­net­ic test­ing start­up to 'con­sid­er' mak­ing an of­fer to buy 23andMe

7 months ago
Financing

Yuhan ends can­cer project with J&J as it signs API deal with Gilead on HIV drugs 

7 months ago
Manufacturing

Gilead­'s Kite un­cou­ples from Fo­s­un in Chi­na as Yescar­ta faces cov­er­age ob­sta­cles

7 months ago
China

Tang Cap­i­tal’s Con­cen­tra bids for Sin­gu­lar Ge­nomics days af­ter Deer­field of­fer

7 months ago

Roivant makes an­oth­er deal, sell­ing Der­ma­vant to Organon for up to $1.2B

7 months ago

No­vo Nordisk signs ge­net­ic med­i­cine pact, ink­ing deal with NanoVa­tion

7 months ago

Im­mat­ics los­es Bris­tol My­er­s' sup­port on Phase 1 bis­pe­cif­ic T cell en­gager

7 months ago
R&D

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

8 months ago
Law

De­bio­pharm, ITM ink up to €300M li­cens­ing deal for can­cer treat­ment

8 months ago

Sanofi buys in­to ra­dio­phar­ma­ceu­ti­cal field with $110M up­front, go­ing af­ter space held by No­var­tis

8 months ago
R&D
Pharma

Gilead part­ners with AI start­up Gen­e­sis Ther­a­peu­tics to make small mol­e­cule drugs

8 months ago
AI

Roivant un­veils its next deal, hop­ing for TL1A-sized po­ten­tial from a shelved Bay­er lung dis­ease ther­a­py

8 months ago

Ex­clu­sive: In­flu­en­tial De­mo­c­rat will op­pose Biose­cure Act ahead of House vote

8 months ago
R&D
China

Lit­tle-known start­up, backed by Fore­site and Sam­sara, swings $60M Chi­na I&I deal

8 months ago
Startups
China

Lil­ly inks obe­si­ty deal with seed-stage RNA start­up as its ge­net­ic med­i­cines ef­fort en­ters the spot­light

8 months ago
Startups

Court's rul­ing on Il­lu­mi­na-Grail deal could sig­nal a lim­it to Eu­ro­pean an­titrust pow­ers

8 months ago
Pharma
Diagnostics

No­var­tis part­ners with small North Car­oli­na biotech to make its bi­o­log­ics more 'con­ve­nien­t'

8 months ago
Startups
Manufacturing

Bay­er part­ners with RNA start­up launched out of Dana-Far­ber

8 months ago
R&D

Pfiz­er part­ners with Flag­ship ge­net­ics start­up Quo­tient on heart and kid­ney drugs

8 months ago
Startups
R&D
First page Previous page 9101112131415 Next page Last page
A service from the Financial Times